Innovative Medicines Canada
Code of Ethical PracticesCode d\éthiques de
Médicaments Novateurs Canada
Table of ContentsTable des matières
FavouritesFavoris
NewsNouvelles
ResourcesRessources
EventsÉvénements
Search for:
Language Menu
ANNEX A - Innovative Medicines Canada Guidelines for Transparency in Stakeholder Funding
6
Business Meetings and Discussions
17
Clinical Evaluation Packages (“Samples”)
13
Collaborations and Partnerships
10
Conferences and Congresses
8
Consultant Meetings
11
Displays
20
Enforcement
1
Guiding Principles
Introduction
9
Learning Programs for Health Care Professionals
14
Loan of Medical Equipment
18
Market Research
4
Members’ Employees
15
Patient Support Programs and Medical Practice Activities
19
Post Registration Clinical Studies
2
Privacy of Patient Information
12
Provision of Funding
7
Retaining the Services of a Stakeholder
5
Scientific Exchanges
16
Service-Oriented Items
3
Transparency
My FavouritesMes Favoris
WordPress › Error
There has been a critical error on this website.
Learn more about troubleshooting WordPress.